We are live on ! Find out more
AIA

AIMZ Investment Advisors Portfolio holdings

AUM $324M
1-Year Est. Return 18.77%
This Fund
S&P 500
This Quarter Est. Return
-12.04%
1 Year Est. Return
+18.77%
3 Year Est. Return
+63.89%
5 Year Est. Return
+85.69%
10 Year Est. Return
+323.28%
AUM
$209M
AUM Growth
-$34.7M
Cap. Flow
-$2.63M
Cap. Flow %
-1.26%
Top 10 Hldgs %
32.75%
Holding
116
New
Increased
22
Reduced
47
Closed
7

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$4.05M
2
NVDA icon
NVIDIA
NVDA
+$327K
3
ISRG icon
Intuitive Surgical
ISRG
+$299K
4
DIS icon
Walt Disney
DIS
+$221K
5
AFL icon
Aflac
AFL
+$214K

Sector Composition

Rank Sector Weight
1 Healthcare 30.84%
2 Technology 29.7%
3 Industrials 13.23%
4 Financials 7.72%
5 Consumer Discretionary 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$13.6M 6.52%
99,493
-288
-0.3% -$43.6K
MSFT icon
2
Microsoft
MSFT
$2.84T
$9.04M 4.33%
35,181
-46
-0.1% -$12.5K
QCOM icon
3
Qualcomm
QCOM
$176B
$6.79M 3.26%
53,178
+7
+0% +$951
REGN icon
4
Regeneron Pharmaceuticals
REGN
$68.8B
$6.57M 3.15%
11,114
-50
-0.4% -$32.5K
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$121B
$6.52M 3.13%
23,145
-25
-0.1% -$6.69K
INFY icon
6
Infosys
INFY
$45B
$6.07M 2.91%
327,776
+74
+0% +$1.47K
META icon
7
Meta Platforms (Facebook)
META
$1.51T
$5.34M 2.56%
33,116
-8
-0% -$1.54K
TROW icon
8
T. Rowe Price
TROW
$25B
$5.1M 2.45%
44,927
+9,625
+27% +$1.22M
CHRW icon
9
C.H. Robinson
CHRW
$22B
$4.69M 2.25%
46,247
-21
-0% -$2.19K
GILD icon
10
Gilead Sciences
GILD
$161B
$4.57M 2.19%
74,009
-236
-0.3% -$14.6K
INCY icon
11
Incyte
INCY
$23.5B
$4.31M 2.06%
56,682
NTAP icon
12
NetApp
NTAP
$32.9B
$4.28M 2.05%
65,657
-389
-0.6% -$28K
AZN icon
13
AstraZeneca
AZN
$263B
$4.16M 1.99%
31,455
-56
-0.2% -$7.35K
EXPD icon
14
Expeditors International
EXPD
$22.9B
$4.15M 1.99%
42,580
+7
+0% +$717
BMY icon
15
Bristol-Myers Squibb
BMY
$127B
$4.03M 1.93%
52,269
+3
+0% +$228
CDK
16
DELISTED
CDK Global, Inc.
CDK
$3.8M 1.82%
69,372
-3,334
-5% -$180K
UNH icon
17
UnitedHealth
UNH
$382B
$3.68M 1.76%
7,158
-71
-1% -$35.7K
AMGN icon
18
Amgen
AMGN
$203B
$3.62M 1.74%
14,888
-68
-0.5% -$16.7K
CSCO icon
19
Cisco
CSCO
$450B
$3.24M 1.55%
75,985
-74
-0.1% -$3.54K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.07T
$3.24M 1.55%
11,863
-66
-0.6% -$20.7K
CHKP icon
21
Check Point Software Technologies
CHKP
$13.3B
$3.09M 1.48%
25,364
PRLB icon
22
Protolabs
PRLB
$1.86B
$3.06M 1.47%
63,998
+700
+1% +$32.5K
CTAS icon
23
Cintas
CTAS
$82.4B
$3.01M 1.44%
32,248
-100
-0.3% -$9.74K
WBA
24
DELISTED
Walgreens Boots Alliance
WBA
$2.9M 1.39%
76,599
+1,902
+3% +$81.8K
IBM icon
25
IBM
IBM
$202B
$2.9M 1.39%
20,546
-71
-0.3% -$9.58K

Similar funds

AIMZ Investment Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, AIMZ Investment Advisors held 116 positions worth $209M, down 14% from $243M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

AIMZ Investment Advisors's Q2 2022 filing shows 22 increased, 47 reduced and 7 closed positions. The largest sale was GSK, an estimated $4.05M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • AIMZ Investment Advisors added most to PayPal in Q2 2022, an estimated $2.71M increase.
  • AIMZ Investment Advisors's biggest Q2 2022 reduction was CDK Global, Inc., cutting an estimated $180K.
  • AIMZ Investment Advisors fully exited GSK in Q2 2022, selling an estimated $4.05M.
  • AIMZ Investment Advisors's ten largest holdings make up 33% of its $209M portfolio in Q2 2022.
  • AIMZ Investment Advisors opened 0 new positions and closed 7 in Q2 2022.
  • AIMZ Investment Advisors's portfolio value fell 14% quarter-over-quarter to $209M.

Based on AIMZ Investment Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.